STTK Shattuck Labs Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: STTK

Price (delayed)

$4.88

Market cap

$374.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$285.82M

?
Relative Growth: Rel. Growth: 29
Relative Strength: Rel. Strength: 96
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 35

Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck ...

Highlights
STTK's quick ratio has soared by 155% YoY and by 92% QoQ
Shattuck Labs's EPS has soared by 58% YoY and by 16% from the previous quarter
STTK's net income is up by 29% year-on-year but it is down by 2.2% since the previous quarter
The debt has increased by 29% since the previous quarter but it has declined by 10% year-on-year
Shattuck Labs's gross profit has shrunk by 78% YoY
STTK's revenue has dropped by 78% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.shattucklabs.com
Peers: DLB

Key stats

What are the main financial stats of STTK

STTK stock price

How has the Shattuck Labs stock price performed over time
Intraday
2.74%
1 week
-18.26%
1 month
-29.48%
1 year
320.69%
YTD
33.7%
QTD
-24.11%

Financial performance

How have Shattuck Labs's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$52.66M
Net income
-$49.87M
Gross margin
100%
Net margin
-4,987.4%
Shattuck Labs's gross profit has shrunk by 78% YoY
STTK's revenue has dropped by 78% year-on-year
Shattuck Labs's operating income has increased by 30% YoY but it has decreased by 2.2% QoQ
STTK's net income is up by 29% year-on-year but it is down by 2.2% since the previous quarter

Price vs fundamentals

How does STTK's price correlate with its fundamentals

Growth

What is Shattuck Labs's growth rate over time

Valuation

What is Shattuck Labs stock price valuation
P/E
N/A
P/B
3.64
P/S
547.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
285.82
Shattuck Labs's EPS has soared by 58% YoY and by 16% from the previous quarter
The stock's price to book (P/B) is 109% more than its 5-year quarterly average of 1.7 and 48% more than its last 4 quarters average of 2.4
The company's equity rose by 42% YoY and by 16% QoQ
STTK's price to sales (P/S) is 84% higher than its last 4 quarters average of 290.4
STTK's revenue has dropped by 78% year-on-year

Efficiency

How efficient is Shattuck Labs business performance
The ROE has grown by 24% year-on-year and by 7% since the previous quarter
STTK's return on assets is up by 19% year-on-year and by 4.9% since the previous quarter
The ROIC is down by 3.9% QoQ
Shattuck Labs's ROS has decreased by 2.2% from the previous quarter

Dividends

What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STTK.

Financial health

How did Shattuck Labs financials performed over time
STTK's quick ratio has soared by 155% YoY and by 92% QoQ
STTK's current ratio has surged by 143% year-on-year and by 89% since the previous quarter
The debt is 98% smaller than the equity
The company's equity rose by 42% YoY and by 16% QoQ
The company's debt to equity fell by 33% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.